secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K/A
Filed at:   2024-06-13T23:59:59+00:00
Accession:  0001493152-24-023626
Event type: debt
Sentiment:  neutral
Materiality: 0.10
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma enters two loan agreements totaling AUD $120,000 at 12% interest
--------------------------------------------------------------------------------

- First loan of AUD $20,000 on June 3, 2024; 12% annual interest; matures June 3, 2025.
- Second loan of AUD $100,000 on June 5, 2024; 12% annual interest; matures June 5, 2025.
- Both loans for general working capital; company may prepay without penalty.
- Loans issued as unregistered securities under Section 4(a)(2) and Rule 506.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224023626/0001493152-24-023626-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224023626/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023626

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer